James D. Griffin (oncologist) explained

James D. Griffin
Birth Name:James Douglas Griffin
Birth Place:Syracuse, New York

James D. Griffin is an American physician-scientist. He is currently Professor of Medicine at Harvard Medical School, Chair of Medical Oncology at Dana–Farber Cancer Institute, and Director of Medical Oncology at Brigham and Women's Hospital.[1] [2] He is considered an expert in medical oncology and is widely recognized for his research in the clinical and biologic aspects of hemotologic malignancies.

Griffin completed a Bachelor of Arts at Brown University in 1970. He attended Harvard Medical School, earning his M.D. in 1974. Griffin completed his residency at Johns Hopkins Hospital, a hematology fellowship at Massachusetts General Hospital, and a medical oncology fellowship at Dana–Farber Cancer Institute.[3]

He is on the scientific advisory boards of Phio Pharmaceuticals, the Georgetown Lombardi Comprehensive Cancer Center, and the Johns Hopkins Cancer Center.[4]

Griffin was born in Syracuse, New York. He is a seventh-generation Irish American.[5]

Notes and References

  1. Web site: James D. Griffin, MD - Dana-Farber Cancer Institute Boston, MA. 2022-02-05. www.dana-farber.org.
  2. Web site: James D. Griffin, MD - DF/HCC. 2022-02-05. www.dfhcc.harvard.edu.
  3. Web site: Corporation. RXi Pharmaceuticals. RXi Pharmaceuticals Appoints Medical Oncology Expert, Dr. James Griffin, to Scientific Advisory Board. 2022-02-05. www.prnewswire.com. en.
  4. Web site: walid. 2021-06-28. Phio Pharmaceuticals About Us. 2022-02-05. phiopharma.com. en-US.
  5. Web site: James Griffin. 2022-02-05. Irish America. en-US.